Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-190-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-02-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20110216.11.3-190-000"2
lpv:hasSubsequent	lp_eu:2011-02-16-Speech-3-191-0002
lpv:speaker	lp:Luís Paulo Alves2
lpv:spokenAs	unknown; Partido Socialista (2009-07-14--2014-06-30)3 member; REGI (2009-07-16--2012-01-18)3 substitute; Delegation to the EU-Turkey Joint Parliamentary Committee (2009-09-16--2014-06-30)3 member; S&D (2009-07-14--2014-06-30)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; AGRI (2009-07-16--2012-01-18)3 substitute; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"In light of the alarming increase in falsified medicines, I am voting for this report. The compromise reached in the series of trialogues during the Belgian Presidency demonstrated the importance of harmonising safety issues, especially as regards non-prescription medicines, and the conditions surrounding the removal and replacement of medicines by packagers, which will thus lead to increased transparency in the sector. The implementation of penalties has also enhanced these measures, which are considered vital in the fight against falsified medicines in legal supply networks."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph